MLH1 and endometrial cancer: Hypermethylation of the CpG islands of the MLH1 promoter can lead to the accumulation of mismatched nucleotides and the generation of microsatellite instability [59] which have been linked to the poor prognosis of several tumour types but predominantly in colorectal cancers and endometrial cancers [60,61].